Abstract
This study uses 2 large US health care claims databases (Medicare fee-for-service and the US Food and Drug Administration’s Sentinel System) to examine systemic corticosteroid use among nonhospitalized patients with COVID-19.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have